Monte Rosa Therapeutics, Inc.

GLUE· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$10.75-1.07%

2026-10-30

Financials

Valuation Metrics

Monte Rosa Therapeutics, Inc.'s Market Cap is $908M. At end of 2025 it was $1.03B. Ranked #2447 of 3,114 in US market (top 79%), #1003 of 1,469 on NASDAQ (top 68%), #183 of 265 in Pharmaceuticals, Biotechnology & Life Sciences (top 69%) by Market Cap.

Investment Metrics(as of 2026-10-30)

Metric	Value	Rank
Size
Market Cap	$908M	US#2,447/3,114 Sec#183/265
Revenue	$29M	US#2,780/3,114 Sec#157/265
Net Income	$-161M	US—/3,114 Sec—/265
Total Assets	$696M	US#2,629/3,114 Sec#132/265
Net Assets	$487M	US#2,239/3,114 Sec#109/265
Value
P/B	1.86x	US#1,218/3,114 Sec#57/265
P/S	31.62x	US#2,895/3,114 Sec#159/265
FCF Yield	-7.85%	US—/3,114 Sec—/265
Profitability
ROE	-33.06%	US#2,586/3,114 Sec#123/265
ROA	-23.15%	US#2,829/3,114 Sec#140/265
Op. Margin	-633.04%	US#2,790/3,114 Sec#158/265
Revenue Growth	-83.86%	US#2,720/3,114 Sec#175/265
Earnings Growth	-766.65%	US#1,991/3,114 Sec#68/265
Financial Health
Debt Ratio	43.31%	US#489/3,114 Sec#132/265
Total Debt	$38M	US#2,660/3,114 Sec#166/265
FCF	$-71M	US#2,582/3,114 Sec#126/265
Cash	$90M	US#2,288/3,114 Sec#184/265
Current Ratio	9.52x	US#268/3,114 Sec#83/265
Performance
1Y Return	-17.34%	US#1,152/3,114 Sec#113/265
1M Return	-9.86%	US#2,401/3,114 Sec#155/265
From 52W High	-58.27%	US#2,795/3,114 Sec#218/265
1Y MDD	-61.52%	US#2,766/3,114 Sec#210/265
Trading
Volume	1,090,687 shares	US#1,490/3,114 Sec#137/265
Trading Value	$12M	US#2,211/3,114 Sec#165/265
Per Share
EPS	$-1.91	US—/3,114 Sec—/265
BPS	$5.77	US#2,211/3,114 Sec#118/265